Showing results (881-890 of 1,794) with videos related to
Sort By:
Pageof 180
Mabs|March 2, 2012
Rituximab in immunologic glomerular diseasesA Ahsan Ejaz, Abdo Asmar, Mourad M Alsabbagh, et al.Mabs|October 6, 2021
Quantification of natural abundance NMR data differentiates the solution behavior of monoclonal antibodies and their fragmentsDavid Ban, Cory T Rice, Mark A McCoyMabs|June 27, 2019
Characterization of a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody for cancer immunotherapyXiaojie Yu, Xiao Huang, Xiuxiu Chen, et al.Mabs|June 5, 2019
Conjugation of DM1 to anti-CD30 antibody has potential antitumor activity in CD30-positive hematological malignancies with lower systemic toxicityYijun Shen, Tong Yang, Xuemei Cao, et al.Mabs|October 15, 2019
Direct measurement of light and heavy antibody chains using ion mobility and middle-down mass spectrometryRafael D Melani, Kristina Srzentić, Vincent R Gerbasi, et al.Mabs|March 16, 2022
The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIaYuki Yamaguchi, Natsumi Wakaizumi, Mine Irisa, et al.Mabs|April 28, 2022
Predicting antibody binders and generating synthetic antibodies using deep learningYoong Wearn Lim, Adam S Adler, David S JohnsonMabs|October 11, 2021
Structure-based charge calculations for predicting isoelectric point, viscosity, clearance, and profiling antibody therapeuticsNels Thorsteinson, John R Gunn, Kenneth Kelly, et al.Mabs|January 25, 2022
Machine learning prediction of antibody aggregation and viscosity for high concentration formulation development of protein therapeuticsPin-Kuang Lai, Austin Gallegos, Neil Mody, et al.Mabs|March 3, 2022
A strategy for the efficient construction of anti-PD1-based bispecific antibodies with desired IgG-like propertiesJie Zhao, Liangfeng Jiang, Haodong Yang, et al.Pageof 180